Medical research Fundação Oswaldo Cruz, known as Friocruz, announced it will be responsible for coordinating the World Health Organization “Solidarity” clinical study in Brazil. The prominent biomedical institution will lead tests concerning new treatments against Covid-19, including patients that have already been hospitalized.
Among the drugs — to be tested on at least 1,200 patients — Fiocruz listed hydroxychloroquine, which President Jair Bolsonaro believes to be a potential cure for the virus, despite a lack of evidence. The research will cost BRL 4 million, funded by the Health Ministry.
Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…
“This is f***ing corruption, it has to change,” protested an irate John Textor, owner of…
Eduardo Leite, governor of the southern Brazilian state of Rio Grande do Sul, on Wednesday…
Moody’s is the latest rating agency to improve its assessment of Brazil, bumping up the…
Other finalists include the Harvard Business Review, Fortune, Condé Nast, and the NFL
The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…